Search

Author/Creator Chang, Alan T.

2. S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE. (October 2022)

Authors:
Chehade, Mirna; Genta, Robert M.; Leiman, David A.; Peterson, Kathryn A.; Spergel, Jonathan; Wechsler, Joshua; Bortey, Enoch; Chang, Alan T.; Hirano, Ikuo
Other Names:
Dellon Evan presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e316
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S449 Lirentelimab (AK002) Safety and Efficacy in Patients With Higher Eosinophil Thresholds: Supplementary Analysis of Phase 2/3 EoE KRYPTOS Trial. (October 2022)

Authors:
Chehade, Mirna; Genta, Robert M.; Leiman, David A.; Peterson, Kathryn A.; Spergel, Jonathan; Wechsler, Joshua; Bortey, Enoch; Chang, Alan T.; Hirano, Ikuo
Other Names:
Dellon Evan presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e318
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Symptomatic Patients Suspected of Eosinophilic Gastritis and/or Enteritis Have Elevated Mucosal Mast Cell Counts Without Eosinophilia: A New Diagnostic Entity?: 1244. (October 2019)

Authors:
Murray, Joseph A.; Dellon, Evan S.; Peterson, Kathryn A.; Falk, Gary W.; Chehade, Mirna; Genta, Robert M.; Gonsalves, Nirmala; Rothenberg, Marc E.; Khoury, Paneez; Leung, John; Bledsoe, Adam C.; Shaw, Camilla; Rasmussen, Henrik S.; Singh, Bhupinder; Chang, Alan T.; Youngblood, Bradford A.; Kamboj...
Journal:
American journal of gastroenterology
Issue:
Volume 114 (2019)ACG Abstracts 1:Supplement
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗